Dual Defense(TM) Technology Latest Innovation from COPPERTONE(R) Solar Research Center
(Photo: http://www.newscom.com/cgi-bin/prnh/20090127/NY62932)
An international beauty icon, Ms. Shields stays current on the latest trends in maintaining optimal skin health and understands how year-round sun exposure can slowly deplete unprotected skin of its radiance over time. "I am excited to work with the COPPERTONE brand to help raise awareness on the need for year-round sun protection and the benefits of antioxidants in promoting natural skin repair," Shields said.
COPPERTONE(R) Adds Antioxidants to Help Replenish Skin
The COPPERTONE NutraShield product line - the latest innovation from the COPPERTONE Solar Research Center - evolves the brand beyond its suncare roots to a new level of antioxidant-enhanced suncare. The power of NutraShield lies in its Dual Defense technology, combining a broad spectrum sunscreen, to protect against UVA and UVB rays, and antioxidants to replenish skin, supporting its natural repair process.
"The changing environment is altering the way people think about the sun's effects on skin. Our research indicates that consumers want not only broad spectrum sunscreens with higher sun protection factors (SPFs) to help prevent sun damage, but also formulas with antioxidants that can help promote natural skin repair," said
The COPPERTONE NutraShield line includes a SPF 70+ Faces lotion as well as SPF 70+ and SPF 30 lotions for the body. The product line is available online and at mass retailers across the country.
About COPPERTONE
COPPERTONE, Water BABIES, COPPERTONE SPORT, ultraGUARD and COPPERTONE KIDS are registered trademarks and NutraShield and Dual Defense are trademarks of Schering-Plough HealthCare Products, Inc.
About Schering-Plough
Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough, an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in
SCHERING-PLOUGH DISCLOSURE NOTICE:
The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to potential market for COPPERTONE(R) NUTRASHIELD(TM). Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A. "Risk Factors" in the third quarter 2008 10-Q, filed
SOURCE Schering-Plough Corporation